Nanjing Vazyme Biotech Co., Ltd.SSE: 688105

Notice on Convening the 1st Extraordinary General Meeting in 2026

· Issued by Nanjing Vazyme Biotech Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 9 pages · Chinese

Summary by 6ix AI

The meeting is scheduled for June and will include both on-site and online voting options for shareholders. Key agenda items include the election of new board members, with specific candidates listed for both independent and non-independent director positions. Shareholders must register to attend the meeting and can delegate their voting rights to representatives if necessary.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Notice on Convening the 1st Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Nanjing Vazyme Biotech Co., Ltd. on 6ix

Earlier from Nanjing Vazyme Biotech

Later from Nanjing Vazyme Biotech

All Nanjing Vazyme Biotech news releases